Why the study?
Does reoperation safely relieve hemolysis in patients with hemolytic anemia complicating mitral valve repair?
Does reoperation safely relieve hemolysis in patients with hemolytic anemia complicating mitral valve repair?
Reoperation is safe and effective for relieving hemolytic anemia caused by minor regurgitation impacting prosthetic material after mitral valve repair.
Answers are grounded in this paper and cite their sources.
Supports reoperation for refractory hemolysis after mitral repair; leaves open need for prospective data on timing and durability.
Relatively minor degrees of regurgitation after mitral valve repair can produce hemolytic anaemia which is manifested within the first few postoperative months. Most patients are highly symptomatic because of anaemia. The mechanism of red cell destruction is a high velocity eccentric stream of blood impacting on a small area of a prosthetic ring or pledget. This process retards endothelialization of the ring. Reoperation with re-repair or mitral valve replacement is safe and effectively relieves the hemolysis.
No takes yet. Share an insight, caveat, or question.
Robert J. Cerfolio (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: